Skip to main content

Table 3 General information and pharmacoeconomic data on antibacterial prescriptions

From: An outpatient antibacterial stewardship intervention during the journey to JCI accreditation

Indicators

First phase

Second phase

 

(March, 2012)

(March, 2013)

Kinds of antibacterials in outpatient pharmacy

38

16

Kinds of the third line antibacterials

1

0

Kinds of the second line antibacterials

17

4

Kinds of the first line antibacterials

20

12

Kinds of i.v. antibacterials

22

0

Kinds of oral antibacterials

16

16

Total number of prescriptions for outpatients

88425

90459

Total number of prescriptions containing antibacterials

11194

8920

Proportion of prescriptions containing antibacterials#

12.7%

9.9%

Proportion of prescriptions containing non-restricted antibacterials#

55.1%

69.6%

Proportion of prescriptions containing restricted antibacterials#

44.7%

30.4%

Proportion of prescriptions containing special-grade antibacterials#

0.14%

0

Total expenditure on antibacterials for outpatients (million CNY)

1.4760

0.9644

Proportion of expenditure on antibacterials relative to all medications

6.9%

4.1%

Proportion of expenditure on i.v. antibacterials relative to all antibacterials

30.5%

0

Sum of DDDs of antibacterials for outpatients

65930

61403

Proportion of DDDs of oral antibacterials for outpatients relative to all antibacterials#

94.0%

100%

  1. Notes: # P < 0.01 (first phase vs second phase). Differences between the two phases were tested for statistical significance using Pearson’s Chi-square test. A P value < 0.05 was considered to be statistically significant. A P value < 0.01 was considered to be highly significant. CNY: Chinese Yuan Renminbi. DDDs: number of defined daily doses (total dose consumed/defined daily dose). Daily expenditure = overall expenditure/DDDs.